Dhuwit awis perusahaan: Sage Therapeutics, Inc. (SAGE)

SAGE (Sage Therapeutics) - tandha merek perusahaan

Sage Therapeutics, Inc. (SAGE) relies on contract manufacturers for drug production while maintaining rigorous internal quality control. The cash runway metric visualizes financial autonomy, with 0.36 marking a new level. Business stability is ensured by the demand for neuropsychiatric drugs regardless of economic conditions, while the risks associated with external laboratories are mitigated by strict management oversight of clinical trials.

Sage Therapeutics Inc. - Gunggung dana dhuwit perusahaan SAGE (periode 04.07.2022 - 16.08.2025)

Rincian metrik lan analitis perusahaan Sage Therapeutics Inc. (SAGE)

- indikator kapitalisasi bursa perusahaan:
Analisis dhasar perusahaan:Sage Therapeutics, Inc. SAGE
Produk merek Sage Therapeutics

This indicator serves as a key criterion for assessing the issuer's financial stability. It captures the net cash balance, determining real liquidity and the risk of cash flow gaps. Analyzing the cash liquidity metric allows for tracking the actual burn rate. For Sage Therapeutics, Inc. (SAGE), this reserve is critical for funding neurobiology research and development. A sufficient volume of funds guarantees the company's leadership in creating innovative depression treatments.

Pesaing langsung

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Posisi dhuwit perusahaan Voyager Corp|Neumora Corp - Volume dana dhuwit perusahaan|scilexholding.com (SCLX) - Dhuwit awis perusahaan|Tevogen Bio Holdings, Inc. (TVGN) - Dana dhuwit perusahaan|Alpha Cognition Corp (ACOG) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan CGTX|Dhuwit awis lan setara dhuwit awis perusahaan IKT (Inhibikase)|Volume dana dhuwit perusahaan SAVA|Assertio - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan COYA (Coya Therapeutics)|Volume dana dhuwit perusahaan Vistagen Therapeutics VTGN|OVID: Dhuwit awis perusahaan|ABOS - Volume dana dhuwit perusahaan|CRVO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alterity Therapeutics Ltd. (ATHE)|Dana dhuwit perusahaan Clene Inc.|pepgen.com (PEPG) - Aset likuid perusahaan|Dhuwit awis perusahaan JUNS (jupiterneurosciences.com)|Dana dhuwit perusahaan RLMD (Relmada Corp)|Annovis Bio, Inc. - Dhuwit awis perusahaan|Posisi dhuwit perusahaan Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Volume dana dhuwit perusahaan|KLTO - Volume dana dhuwit perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Dhuwit awis perusahaan|RVPH - Aset likuid perusahaan|Dana dhuwit perusahaan MetaVia|Dhuwit awis lan setara dhuwit awis perusahaan NRXS (neuraxis.com)|Dana dhuwit perusahaan Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan NEUP (Neuphoria Therapeutics)|Sisa dhuwit perusahaan NERV|ATHA - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan ADXN|ALZN (Alzamend Neuro) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan CYCN|PTIX (Protagenic Therapeutics, Inc.) - Volume dana dhuwit perusahaan|KTTA: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Cortigent Medical (CRGT)|ATXI - Cadangan dhuwit perusahaan|Volume dana dhuwit perusahaan BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Cadangan dhuwit perusahaan|CHRO: Dhuwit awis perusahaan|Eliem Therapeutics Inc. (ELYM) - Dhuwit awis perusahaan|Intra-Cellular Therapies Inc. (ITCI) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan NKGN (NKGen Biotech Inc)|Volume dana dhuwit perusahaan NRBO|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE